blogs created to prevent or detect a crime

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime

Tuesday, 26 June 2012

GSK - in no great rush to release Paxil CR (Seroxat) Japan - more FIDDAMAN bullshit revealed

Dainippon Sum.Pharma : Anti-depressant Paxil CR Tablets newly launched


June 22, 2012

Anti-depressant Paxil® CR Tablets newly launched

GlaxoSmithKline K.K. Dainippon Sumitomo Pharma Co., Ltd.

GlaxoSmithKline K.K. (President: Philippe Fauchet, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) announces that it has launched its anti-depressant Paxil® CR Tablets 12.5mg and Paxil® CR Tablets 25mg (paroxetine hydrochloride hydrate, hereinafter referred to as Paxil® CR Tablets, CR stands for Controlled Release) in Japan on June 22, following its NHI price listing on the same day.

GSK and Dainippon Sumitomo Pharma Co., Ltd. (President: Masayo Tada, Head Office: Chuo-ku, Osaka, hereinafter referred to as DSP) have started co-promoting Paxil® CR Tablets from April 1, 2012.

Paxil® CR tablets is the controlled-release1 formulation of Paxil® tablets, an SSRI (selective serotonin reuptake inhibitor) anti-depressant. It received regulatory approval in Japan from MHLW on 18 January 2012 for the indication of depression and depressive state. Overseas, development of anti-depressants using new formulation technology are being conducted actively and with the approval of Paxil® CR Tablets, Japan too has entered the era of controlled-release formulations. Paxil® CR Tablets was approved in the US in 1999 and as of June 2011, has been approved and widely used in over 40 countries worldwide.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.